What long-term monitoring is needed for the management of juvenile idiopathic arthritis (JIA)?

Updated: Jul 25, 2019
  • Author: David D Sherry, MD; Chief Editor: Lawrence K Jung, MD  more...
  • Print
Answer

A complete blood cell count and measurement of liver enzymes and serum creatinine should be part of routine follow-up in JIA patients. For JIA patients receiving NSAIDs on a long-term daily basis, these tests, plus urinalysis, should be done twice yearly; in patients taking these agents 3-4 days per week, testing should be repeated annually.

In JIA patients taking methotrexate, these tests should be conducted approximately 1 month after initiation of routine use and approximately 1-2 months after any increase in dose. If prior results were normal and the patient is on a stable dose, the tests can be repeated approximately every 3-4 months.

In JIA patients taking TNF inhibitors, these tests should be repeated approximately every 3-6 months. Tuberculosis screening should be repeated approximately once yearly.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!